# Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

> **NCT07284589** · PHASE2 · RECRUITING · sponsor: **Akiva Mintz** · enrollment: 200 (estimated)

## Conditions studied

- Healthy (Controls)
- Healthy Volunteers
- Neuroendocrine (NE) Tumors

## Interventions

- **DRUG:** 68Ga-Dotatate

## Key facts

- **NCT ID:** NCT07284589
- **Lead sponsor:** Akiva Mintz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-11
- **Primary completion:** 2030-04-30
- **Final completion:** 2030-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07284589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07284589, "Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07284589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*